ArticleTherapeutic advances in medical oncology2023

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study.

Yuan Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.